Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States

被引：0
|
作者：
M. L. Slattery
C. Sweeney
R. Wolff
J. Herrick
K. Baumgartner
A. Giuliano
T. Byers
机构：
[1] University of Utah,Department of Internal Medicine, The Cancer Research and Treatment Center, Epidemiology and Cancer Prevention Program
[2] University of New Mexico Health Science Center,undefined
[3] University of Arizona,undefined
[4] University of Colorado School of Medicine,undefined
[5] University of Louisville,undefined
[6] Moffitt Cancer Center,undefined
来源：
Breast Cancer Research and Treatment | 2007年 / 104卷
关键词：
Breast cancer; Insulin; Obesity; HRT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：197 / 209
页数：12
相关论文
共 50 条
  • [31] IGF1(CA)19 and IGFBP-3-202A/C Gene Polymorphism and Cancer Risk: A Meta-analysis
    Quan, Hongyu
    Tang, Hao
    Fang, Li
    Bi, Jianjun
    Liu, Yunsheng
    Li, Hongli
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2014, 69 (01) : 169 - 178
  • [32] Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk
    McGrath, Monica
    Lee, I-Min
    Buring, Julie
    De Vivo, Immaculata
    GYNECOLOGIC ONCOLOGY, 2011, 120 (02) : 174 - 178
  • [33] Significant changes in circulating plasma levels og IGF1 and IGFBP3 after conventional or dose-intensified adjuvant treatment of breast cancer patients with one to three positive lymph nodes
    Kuemmel, S.
    Eggemann, H.
    Lueftner, D.
    Gebauer, N.
    Buehler, H.
    Schaller, G.
    Schmid, P.
    Kreienberg, R.
    Emons, G.
    Kriner, A.
    Elling, D.
    Blohmer, J. -U.
    Thomas, A.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2007, 22 (03) : 186 - 193
  • [34] IGF-1, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies
    Rinaldi, S
    Toniolo, P
    Muti, P
    Lundin, E
    Zeleniuch-Jacquotte, A
    Arslan, A
    Micheli, A
    Lenner, P
    Dossus, L
    Krogh, V
    Shore, RE
    Koenig, KL
    Riboli, E
    Stattin, P
    Berrino, F
    Hallmans, G
    Lukanova, A
    Kaaks, R
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2005, 14 (06) : 493 - 496
  • [35] Disruption of FOXO3a-miRNAs mediated feedback inhibition of IGF2-IRS1 signaling contributes to Herceptin resistance in HER2 positive breast cancer cells
    He, Zhimin
    CANCER RESEARCH, 2018, 78 (13)
  • [36] RBM8A, a new target of TEAD4, promotes breast cancer progression by regulating IGF1R and IRS-2
    Li, Fang
    Wang, Xiaofei
    Zhang, Jing
    Zhang, Jinyuan
    Jing, Xintao
    Jiang, Qiuyu
    Zhou, Jing
    Cao, Li
    Peng, Hang
    Tong, Dongdong
    Huang, Chen
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [37] Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States
    Martha L. Slattery
    Kathy B. Baumgartner
    Anna R. Giuliano
    Tim Byers
    Jennifer S. Herrick
    Roger K. Wolff
    Breast Cancer Research and Treatment, 2011, 129 : 531 - 539
  • [38] Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States
    Slattery, Martha L.
    Baumgartner, Kathy B.
    Giuliano, Anna R.
    Byers, Tim
    Herrick, Jennifer S.
    Wolff, Roger K.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (02) : 531 - 539
  • [39] IRS2 Copy Number Gain, KRAS and BRAF Mutation Status as Predictive Biomarkers for Response to the IGF-1R/IR Inhibitor BMS-754807 in Colorectal Cancer Cell Lines
    Huang, Fei
    Chang, Han
    Greer, Ann
    Hillerman, Stephen
    Reeves, Karen A.
    Hurlburt, Warren
    Cogswell, John
    Patel, Dharmesh
    Qi, Zhenhao
    Fairchild, Craig
    Ryseck, Rolf-Peter
    Wong, Tai W.
    Finckenstein, Friedrich G.
    Jackson, Jeffrey
    Carboni, Joan M.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (02) : 620 - 630
  • [40] Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population
    Maria A. Loizidou
    Marios A. Cariolou
    Susan L. Neuhausen
    Robert F. Newbold
    Evy Bashiardes
    Yiola Marcou
    Thalia Michael
    Maria Daniel
    Eleni Kakouri
    Panayiotis Papadopoulos
    Simon Malas
    Andreas Hadjisavvas
    Kyriacos Kyriacou
    Breast Cancer Research and Treatment, 2010, 121 : 147 - 156
12345